CellBion Co., Ltd. Sustainability Profile
CellBion Co., Ltd., headquartered in South Korea (KR), is a prominent player in the biotechnology industry, specialising in innovative cell therapy solutions. Founded in 2015, the company has rapidly established itself as a leader in regenerative medicine, focusing on the development and commercialisation of advanced cellular products. With a strong operational presence in Asia and beyond, CellBion offers unique services in cell culture and manipulation, catering to both research and clinical applications. Their flagship products, which include cutting-edge stem cell lines and customised cell solutions, are distinguished by their high purity and efficacy, setting new standards in the field. Recognised for its commitment to quality and innovation, CellBion has achieved significant milestones, positioning itself as a trusted partner in the global biotechnology landscape.
DitchCarbon Score
How does CellBion Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CellBion Co., Ltd.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CellBion Co., Ltd.'s reported carbon emissions
CellBion Co., Ltd., headquartered in South Korea (KR), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, CellBion's climate commitments and initiatives remain unclear, and there is no information available regarding their strategies for addressing carbon emissions or contributing to climate action. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, it is increasingly important for companies to establish clear climate commitments and measurable targets to align with global sustainability goals.
How Carbon Intensive is CellBion Co., Ltd.'s Industry?
How Carbon Intensive is CellBion Co., Ltd.'s Location?
CellBion Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CellBion Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
ABX advanced biochemical compounds GmbH
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.